Collaboration between FESCA, SSoC and BI

Collaboration between FESCA, SSoC and BI

In April, FESCA and the Scleroderma Society of Canada signed an agreement with Boehringer Ingelheim with the intention of working together to advance clinical research and improve awareness of systemic sclerosis (SSc) also known as scleroderma.